£12 million funding awarded to advance innovative cancer projects Twenty-three companies will benefit from a share of £12 million from the Innovate UK Cancer Therapeutics programme. The investment from Innovate UK will drive both early and later stage innovations in cancer therapies, building on UK economic potential in this field. Projects include Proteotype Diagnostics ‘ urine-based ‘multicancer early detection at…
Ben KempSeptember 4, 2024











